期刊文献+

miR-155-5p在宫颈癌血清中的表达及其对宫颈癌细胞的影响 被引量:7

Changes of miR-155-5p in serum of cervical cancer patients and effects of miR-155-5p on cervical cancer cells
下载PDF
导出
摘要 目的:检测miR-155-5p在不同宫颈疾病患者血清中的表达差异,并分析其对宫颈癌细胞增殖、细胞周期和凋亡的影响,探讨miR-155-5p在宫颈癌发生、发展中的可能作用机制。方法:采用SYBR GreenⅠ实时荧光定量PCR法,检测并分析比较miR-155-5p在不同宫颈疾病患者血清中的表达差异。利用miR-155-5p mimic或inhibitor提高或降低宫颈癌细胞中miR-155-5p的表达。CCK-8法和流式细胞术检测宫颈癌细胞的增殖、细胞周期和凋亡。结果:宫颈癌组血清中miR-155-5p的表达高于宫颈炎组和健康对照组(P<0.05),宫颈上皮内瘤样病变组和宫颈癌组血清中miR-155-5p的表达差异无统计学意义(P>0.05)。与空白组、脂质体组和阴性对照组相比,转染100 nmol/L和200 nmol/L miR-155-5p mimic的SiHa细胞中,S期细胞比例升高,凋亡细胞比例降低(P<0.05)。转染100 nmol/L和200 nmol/L miR-155-5p inhibitor的SiHa细胞中,G2/M期细胞比例明显增多(P<0.05)。结论:(1)宫颈癌患者血清中miR-155-5p表达较健康对照人群上调,可能作为宫颈癌早期诊断的肿瘤分子标志物。(2)miR-155-5p对宫颈癌HeLa细胞增殖、细胞周期和凋亡无明显影响。(3)miR-155-5p可促进宫颈癌SiHa细胞进入S期,并抑制SiHa细胞凋亡,提示miR-155-5p可能在宫颈鳞癌发生、发展中起作用。 AIM: To detect the serum level of miR-155-5p in the patients with different cervical diseases, and to analyze its effects on the proliferation, cell cycle and apoptosis of cervical cancer cells. METHODS: SYBR Green I real-time quantitative PCR was used to detect the level of miR-155-5p in the serum of the patients with different cervical diseases, miR-155-5p mimic or inhibitor was used to increase or decrease the expression of miR-155-5p in cervical cancer cells. The proliferation, cell cycle and apoptosis were measured by CCK-8 assay and flow cytometry. RESULTS: The ser- um level of miR-155-5p in cervical cancer group was higher than that in cervicitis group and healthy group. No statistical difference of the serum miR-155-5p level between cervical intraepithelial neoplasia group and cervical cancer group was ob- served. Compared with blank group, liposome group and negative control group, the proportion of S-phase cells increased and apoptotic cells decreased in SiHa ceils transfected with 100 nmol/L and 200 nmol/L miR-155-5p mimic. The propor- tion of G2/M-phase cells increased significantly in SiHa cells transfected with 100 nmol/L and 200 nmol/L miR-155-5p in- hibitor. CONCLUSION: Compared with healthy controls, the serum level of miR-155-5p in the cervical cancer patients increases, and may act as a novel tumor molecular marker for diagnosis of cervical cancer, miR-155-5p has no significant effect on the proliferation, cell cycle and apoptosis of HeLa cell. miR-155-5p may promote SiHa cells to enter S phase and inhibit the apoptosis of SiHa cells.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2013年第12期2193-2200,共8页 Chinese Journal of Pathophysiology
基金 广东省科技计划(No.2011B031800315)
关键词 miR-155-5p 宫颈肿瘤 细胞凋亡 miR-155-5p Cervical neoplasms Apoptosis
  • 相关文献

参考文献5

二级参考文献37

  • 1乌兰娜,吴瑞芳,周艳秋,刘志红,张礼婕,黄秀浓,杜辉.人乳头瘤病毒基因亚型与宫颈病变的关系[J].中国妇产科临床杂志,2005,6(5):346-350. 被引量:102
  • 2Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 3Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 4Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 5Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 6Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 7Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 8Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 9Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 10Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.

共引文献1024

同被引文献48

  • 1Leisching G,Loos B,Botha M,et al. A nontoxic concentration of cisplatin induces autophagy in cervical cancer: selective cancer cell death with antophagy inhibition as an adjuvant treatment [J]. Int J Gynecol Cancer, 2015, 25(3) 380-388.
  • 2Zhang L,Wang T,Wen X,et al. Effect of matrine on HeLa cell adhesion and migration[J]. Eur J Pharmacol, 2007, 563(1-3) 69-76.
  • 3Yang CZ,Ma J,Zhu DW,et al. GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tu- morigenesis and progression in oral squamous cell carcinoma [J]. Ann Oncol, 2014, 25(6) :1215-1222.
  • 4Peng X,Gong F, Chen Y, et al. Autophagy promotes paclitaxel resistance of cervical cancer cells., involvement of Warburg effect activated hypoxia-induced factor 1-a-mediated signaling I-J]. Cell Death Dis, 2014, 14(5) :e1367.
  • 5Nikoli C AR,Petri ET,Klisuri c OR,et al. Synthesis and anti- cancer cell potential of steroidal 16,17-seco-16,17a-dinitriles : i- dentification of a selective inhibitor of hormone-independent breast cancer cells[J].Bioorg Med Chem, 2015, 23(4):703- 711.
  • 6Gocze K,Gombos K,Kovacs K,et al. MicroRNA expressions in HPV-induced cervical dysplasia and cancer[-J. Anticancer Res, 2015, 35(1) :523-530.
  • 7李海东(综述),裘正军(审校).微小RNA miR-155在肿瘤中的研究[J].国际肿瘤学杂志,2010,37(9):652-654. 被引量:6
  • 8刘伏香,谭志琴,龙丹,戈立东.miR-155在子宫内膜癌组织中的表达及其临床意义[J].中国癌症杂志,2011,21(9):684-687. 被引量:10
  • 9葛甜甜,梁勇,付蓉,王国锦,阮二宝,瞿文,王晓明,刘鸿,吴玉红,宋嘉,王化泉,邢莉民,关晶,李丽娟,邵宗鸿.淋巴瘤患者血浆中miR-21、miR-155、miR-210的表达及临床意义[J].中国实验血液学杂志,2012,20(2):305-309. 被引量:16
  • 10刘琳,王月玲,王江芬.miR-21、miR-126、miR-143和miR-373在正常宫颈组织、宫颈癌组织及Hela细胞中的表达差异[J].四川大学学报(医学版),2012,43(4):536-539. 被引量:18

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部